Global disparities in childhood neuroblastoma: trends, burden, and inequities from 1990 to 2021

References

1. 1.↵
   2. Sainero-Alcolado L,
   3. Sjöberg Bexelius T,
   4. Santopolo G,
   5. Yuan Y,
   6. Liaño-Pons J,
   7. Arsenian-Henriksson M.

   Defining neuroblastoma: from origin to precision medicine. Neuro Oncol. 2024; 26: 2174–92.

   OpenUrlCrossRefPubMed
2. 2.↵
   2. Shohet J,
   3. Foster J.

   Neuroblastoma. BMJ. 2017; 357: j1863.
3. 3.
   2. Johnsen JI,
   3. Dyberg C,
   4. Wickström M.

   Neuroblastoma—a neural crest derived embryonal malignancy. Front Mol Neurosci. 2019; 12: 9.

   OpenUrlCrossRefPubMed
4. 4.↵
   2. Sokol E,
   3. Desai AV.

   The evolution of risk classification for neuroblastoma. Children. 2019; 6: 27.

   OpenUrlPubMed
5. 5.↵
   2. Morandi F,
   3. Sabatini F,
   4. Podestà M,
   5. Airoldi I.

   Immunotherapeutic strategies for neuroblastoma: present, past and future. Vaccines. 2021; 9: 43.

   OpenUrlPubMed
6. 6.
   2. Zafar A,
   3. Wang W,
   4. Liu G,
   5. Wang X,
   6. Xian W,
   7. McKeon F, et al.

   Molecular targeting therapies for neuroblastoma: progress and challenges. Med Res Rev. 2021; 41: 961–1021.

   OpenUrlCrossRefPubMed
7. 7.
   2. Qiu B,
   3. Matthay KK.

   Advancing therapy for neuroblastoma. Nat Rev Clin Oncol. 2022; 19: 515–33.

   OpenUrlCrossRefPubMed
8. 8.↵
   2. Salemi F,
   3. Alam W,
   4. Hassani MS,
   5. Hashemi SZ,
   6. Jafari AA,
   7. Mirmoeeni SMS, et al.

   Neuroblastoma: essential genetic pathways and current therapeutic options. Eur J Pharmacol. 2022; 926: 175030.
9. 9.↵
   2. Ward ZJ,
   3. Yeh JM,
   4. Bhakta N,
   5. Frazier AL,
   6. Girardi F,
   7. Atun R.

   Global childhood cancer survival estimates and priority-setting: a simulation-based analysis. Lancet Oncol. 2019; 20: 972–83.

   OpenUrlCrossRefPubMed
10. 10.↵
    2. Steliarova-Foucher E,
    3. Colombet M,
    4. Ries LAG,
    5. Moreno F,
    6. Dolya A,
    7. Bray F, et al.

    International incidence of childhood cancer, 2001–10: a population-based registry study. Lancet Oncol. 2017; 18: 719–31.

    OpenUrlCrossRefPubMed